The 5-HT(1D) receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater

Neuropharmacology

Volumn 36, Issue 1, 1997, Pages 83-91

  Yu, Xian Jie ^a   Cutrer, F M ^a   Moskowitz, M A ^a   Waeber, C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

5 carboxamidotryptamine; 5 H T(1B 1D) receptor; CP 122,288; dura mater; GR 127,935; migraine; neurogenic inflammation; sumatriptan

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 5 CARBAMOYLTRYPTAMINE; 5 METHYLAMINOSULFONYLMETHYL 3 (1 METHYL 2 PYRROLIDINYLMETHYL) 1H INDOLE; MUSCIMOL; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; PERTUSSIS TOXIN; RECEPTOR SUBTYPE; SEROTONIN 1D RECEPTOR; SEROTONIN ANTAGONIST; SUMATRIPTAN; 5-CARBOXAMIDOTRYPTAMINE; BORDETELLA VIRULENCE FACTOR; DRUG DERIVATIVE; OXADIAZOLE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DURA MATER; EXTRAVASATION; FEMALE; FOREBRAIN; GUINEA PIG; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROSTIMULATION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRIGEMINAL NERVE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DURA MATER; ELECTRIC STIMULATION; FEMALE; GUINEA PIGS; MALE; OXADIAZOLES; PERTUSSIS TOXIN; PIPERAZINES; PROSENCEPHALON; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SUMATRIPTAN; TRIGEMINAL NERVE; VIRULENCE FACTORS, BORDETELLA;

EID: 0030612608     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00149-9     Document Type: Article

References (39)

1. Beattie D.T., Connor H.E. The pre- and post-junctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan. Eur. J. Pharmacol. 276:1995;271-276.
2. 1-like receptors: six down and still counting. Trends Pharmacol. Sci. 14:1993;228-231.
3. Bouchelet I., Cohen Z., Case B., Séguéla P., Hamel E. Expression of sumatriptan-sensitive serotonin receptor mRNA in human neuronal and vascular tissues. Soc. Neurosci. Abst. 21:1995;72711.
4. Buzzi M.G., Moskowitz M.A. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99:1990;202-206.
5. Buzzi M.G., Moskowitz M.A., Peroutka S.J., Byun B. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma protein extravasation in rat dura mater. Br. J. Pharmacol. 103:1991;1421-1428.
6. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
7. 1D antagonists. J. Med. Chem. 37:1994;2253-2257.
8. 1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation. Br. J. Pharmacol. 116:1995;2385-2390.
9. 1Dβ receptor in pig caudate membranes. Eur. J. Pharmacol. 264:1994;213-216.
10. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytrytamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
11. A receptor mediated effects of sodium valproate on dural plasma extravasation to substance P and trigeminal stimulation. Br. J. Pharmacol. 116:1995;1661-1667.
12. Lee W.S., Moskowitz M.A. Conformationaly restricted sumatriptan analogues, CP 122,288 and CP 122,638 exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Res. 626:1993;303-305.
13. 1 agonist, on the systemic pulmonary and coronary circulation. Circulation. 87:1993;401-405.
14. Manuel N.A., Wallis D.I., Crick H. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. Br. J. Pharmacol. 116:1995;2647-2654.
15. Markowitz S., Saito K., Moskowitz M.A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7:1987;4129-4136.
16. 1B receptor agonist, blocks neurogenic plasma extravasation within rat but not guinea pig dura mater. Br. J. Pharmacol. 104:1991;3-4.
17. Moskowitz M.A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13:1992;307-311.
18. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 43((suppl 3)):1993;S16-S20.
19. Motulsky H.J., Ransnas L.A. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J. 1:1987;365-374.
20. Narvaez J.A., Aguirre J.A., Van Der Ploeg I., Fuxe K. Intracerebroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y (13-36) in the awake unrestrained male rat. Neurosci. Lett. 140:1992;273-276.
21. Ottervanger J.P., Paalman H.J.A., Boxma G.L., Stricker B.H.C. Transmural myocardial infarction with sumatriptan. Lancet. 341:1993;861-862.
22. 1Dα receptor sites. Neuropharmacology. 34:1995;235-237.
23. 1B receptors. Eur. J. Pharmacol. 290:1995;95-103.
24. Razzaque Z., Longmore J., Hill R.G. Differences in the effects of ketanserin and GR-127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea pig jugular vein. Eur. J. Pharmacol. 283:1995;199-206.
25. 1Dα serotonin receptor gene expression in trigeminal ganglia: implication for antimigraine drug development. Proc. natn. Acad. Sci. U.S.A. 91:1994;3666-3669.
26. 1D receptor antagonist. Behav. Brain Res. 73:1996;157-161.
27. 1D receptors causes hypothermia in the guinea pig. J. Psychopharmacol. 8:1994;14-21.
28. Ullmer C., Schmuck K., Kalkman H.O., Lübbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett. 370:1995;215-221.
29. 1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;479-485.
30. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;263-275.
31. 3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain. Eur. J. Pharmacol. 283:1995;31-46.
32. 1B knockout mice. Soc. Neurosci. Abst. 21:1995;6941.1.
33. 1Dβ receptors. Eur. J. Pharmacol. 287:1995;79-84.
34. 1Dβ receptors. Br. J. Pharmacol. 114:1995;362P.
35. Yu X.-J. and Moskowitz M.A. Neuropeptide Y Y2 receptor mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms. Br. J. Pharmacol. (in press).
36. 1B receptors. Mol. Pharmacol. 49:1996;761-765.
37. 7 receptor subtype coupled to adenylate cyclase stimulation in a clonal cell line. Soc. Neurosci. Abst. 21:1995;5372.
38. 1Dβ receptors. Soc. Neurosci Abst. 22: 528.7.
39. 1Dβ receptor subtypes. Eur. J. Pharmacol. 291:1995;9-15.